The H50Q mutation enhances αα-synuclein aggregation, secretion, and toxicity.
Journal of Biological Chemistry.
Times cited: 41
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
Human Molecular Genetics.
Times cited: 47